Identifying locally actionable strategies to increase participant acceptability and feasibility to participate in Phase I cancer clinical trials.
Staras SAS, Wollney EN, Emerson LE, Silver N, Dziegielewski PT, Hansen MD, Sanchez G, D'Ingeo D, Johnson-Mallard V, Renne R, Fredenburg K, Gutter M, Zamojski K, Vandeweerd C, Bylund CL.
Staras SAS, et al. Among authors: hansen md.
Health Expect. 2023 Dec 2;27(1):e13920. doi: 10.1111/hex.13920. Online ahead of print.
Health Expect. 2023.
PMID: 38041447
Free PMC article.